Our previous study demonstrated the upregulation of TET2 in the cellular and animal model of PD, and further results indicated that TET2 knockdown attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced behavioral impairments in mice (14). This evidence concerns the gene TET2 and Parkinson disease.